Supplementary Figure 2 from Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase–Deficient Renal Cell Carcinoma

Supplementary Figure 2. Treatment details and survival outcomes of patients with metastatic FH-deficient RCC. (A) Swimmer plot showing the treatment response and duration of each patient receiving first-line systemic treatments; (B) Progression-free survival for patients receiving first-line systemic treatments; (C) Overall survival (OS) for patients receiving first-line systemic treatments.